Premium
Synergy Pharmaceuticals, Inc. (SGYP)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
LONDON, Dec. 01, 2021 (GLOBE NEWSWIRE) -- OKYO Pharma Limited ("OKYO" or the "Company") today announces that Bernard Denoyer has been appointed as a non-executive director of the Company with...
Synergy Pharmaceuticals Announces Completion of Sale to Bausch Health PR Newswire NEW YORK, March 6, 2019 NEW YORK, March 6, 2019 /PRNewswire/ -- Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) (the...
Bausch Health Completes Acquisition Of Certain Assets Of Synergy Pharmaceuticals Inc. PR Newswire LAVAL, Quebec, March 6, 2019 LAVAL, Quebec, March 6, 2019 /PRNewswire/ -- Bausch Health Companies...
Synergy Pharmaceuticals Receives Court Approval for the Sale of Its Assets to Bausch Health PR Newswire NEW YORK, March 1, 2019 NEW YORK, March 1, 2019 /PRNewswire/ -- Synergy Pharmaceuticals...
Bausch Health to Acquire Certain Assets of Synergy Pharmaceuticals Inc. PR Newswire LAVAL, Quebec, Feb. 26, 2019 Bausch Health and Synergy to Seek Bankruptcy Court Approval of Sale on March 1...
Synergy Pharmaceuticals Confirms Bausch Health as Successful Bidder for Its Business Assets PR Newswire NEW YORK, Feb. 26, 2019 NEW YORK, Feb. 26, 2019 /PRNewswire/ -- Synergy Pharmaceuticals...
Bausch Health Enters Into Definitive "Stalking Horse" Agreement To Acquire Substantially All The Assets Of Synergy Pharmaceuticals Inc. PR Newswire LAVAL, Quebec, Dec. 12, 2018...
Synergy Pharmaceuticals Announces Agreement for Bausch Health to Acquire Its Business Assets Company Initiates Voluntary Chapter 11 Process to Effectuate Sale; Secures Commitment for DIP...
Synergy Pharmaceuticals Inc. (NASDAQ:SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today reported its...
Synergy Pharmaceuticals Inc. (NASDAQ: SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today announced that...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
